Asher Begleiter
Impact in
- Toxicology top 0.2%
- Bioactive Compounds and Antitumor Agents
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Toxicology 32
- Bioactive Compounds and Antitumor Agents 32
- Genetics 15
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Gerald J. Goldenberg (16 shared papers)Marsha K. Leith (15 shared papers)James B. Johnston (21 shared papers)Michael R. A. Mowat (12 shared papers)Amos Buchner (9 shared papers)Hing-Yat Peter Lam (5 shared papers)Douglas S. Johnson (2 shared papers)Lyonel G. Israels (9 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (6 papers)Biochemical Pharmacology (6 papers)Molecular Pharmacology (4 papers)Leukemia Research (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- CanadaUnited StatesIsrael
In The Last Decade
Asher Begleiter
98 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 110
- Toxicology 495
- Genetics 296
- Molecular Biology 1.5k
- Oncology 519
- Periodontics 74
Countries citing papers authored by Asher Begleiter
This map shows the geographic impact of Asher Begleiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Begleiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Begleiter more than expected).
Fields of papers citing papers by Asher Begleiter
This network shows the impact of papers produced by Asher Begleiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Begleiter. The network helps show where Asher Begleiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Asher Begleiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 158 | |
| 2 | 1997 | 126 | |
| 3 | 1979 | 120 | |
| 4 | Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. | 1997 | 71 |
| 5 | Evidence for active transport of melphalan by two amino acid carriers in L5178Y lymphoblasts in vitro. | 1979 | 71 |
| 6 | 1996 | 69 | |
| 7 | 2000 | 69 | |
| 8 | 1997 | 66 | |
| 9 | 2000 | 55 | |
| 10 | 1989 | 54 | |
| 11 | 1997 | 53 | |
| 12 | 2003 | 51 | |
| 13 | 1975 | 51 | |
| 14 | Cytocidal action of the quinone group and its relationship to antitumor activity. | 1983 | 50 |
| 15 | 1983 | 49 | |
| 16 | 2004 | 49 | |
| 17 | 1980 | 45 | |
| 18 | 1976 | 45 | |
| 19 | 1992 | 41 | |
| 20 | 1979 | 41 |
About Asher Begleiter
Asher Begleiter is a scholar working on Toxicology, Genetics, Organic Chemistry, Molecular Biology and Oncology, having authored 99 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (32 papers), Cancer therapeutics and mechanisms (21 papers), Genomics, phytochemicals, and oxidative stress (16 papers), Synthesis and Biological Evaluation (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Synthesis and biological activity (10 papers), Acute Lymphoblastic Leukemia research (7 papers) and Oral and Maxillofacial Pathology (6 papers). The work is most often cited by research in Toxicology (495 citations), Genetics (296 citations), Molecular Biology (1.5k citations), Oncology (519 citations) and Periodontics (74 citations). Asher Begleiter has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include Gerald J. Goldenberg, Marsha K. Leith, James B. Johnston, Michael R. A. Mowat, Amos Buchner, Hing-Yat Peter Lam, Douglas S. Johnson, Lyonel G. Israels, James W. Lown and A. Richard Morgan. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, Molecular Pharmacology, Leukemia Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.